BlobNotFoundThe specified blob does not exist. RequestId:12d68c1a-201e-0092-0e02-12afdf000000 Time:2019-05-24T07:30:45.8086451Z BlobNotFoundThe specified blob does not exist. RequestId:8cca6695-201e-011e-5f02-12a4d1000000 Time:2019-05-24T07:30:45.8118537Z BlobNotFoundThe specified blob does not exist. RequestId:e8796097-e01e-00e2-1302-12dc1b000000 Time:2019-05-24T07:30:45.8128165Z
BlobNotFoundThe specified blob does not exist. RequestId:a9986616-e01e-002e-1602-12b8ae000000 Time:2019-05-24T07:30:45.8156414Z
BlobNotFoundThe specified blob does not exist. RequestId:ad7c5987-e01e-006a-7202-1264c2000000 Time:2019-05-24T07:30:45.8145014Z

精准筛查患者或成肿瘤免疫攻克重点

健康 来源:央视网 2019年01月03日 09:41 A-A+ 二维码
扫一扫 手机阅读

原标题:

央视网消息:目前,肿瘤的免疫治疗研究在全球方兴未艾,我国相关药物的研发势头也很迅猛,但是依然存在亟待突破的难点。这些领域的突破被认为是未来抢占市场先机的关键所在。

据了解,目前全球已经获批的肿瘤免疫药物治疗的对象主要集中在约25%的癌症患者身上,而其余75%的患者由于个体差异,对这类药物并不敏感。因此,未来这些肿瘤患者群体将是肿瘤免疫治疗研究的重点方向。

BlobNotFoundThe specified blob does not exist. RequestId:dff8a289-b01e-00b5-5102-123596000000 Time:2019-05-24T07:30:45.8196622Z
BlobNotFoundThe specified blob does not exist. RequestId:67fcfe34-a01e-00a1-5502-12f6f2000000 Time:2019-05-24T07:30:45.8183358Z 肿瘤 | 免疫治疗
BlobNotFoundThe specified blob does not exist. RequestId:d6701f09-501e-0051-3302-12269c000000 Time:2019-05-24T07:30:45.8202869Z
我要纠错编辑:邹杨 责任编辑:张福伟
BlobNotFoundThe specified blob does not exist. RequestId:520cdf8d-301e-00c9-0602-12a8a3000000 Time:2019-05-24T07:30:45.8226482Z
BlobNotFoundThe specified blob does not exist. RequestId:90be38da-a01e-012d-7002-12fdfc000000 Time:2019-05-24T07:30:45.8233431Z
BlobNotFoundThe specified blob does not exist. RequestId:60bf95d9-b01e-00f1-3502-12e9fa000000 Time:2019-05-24T07:30:45.8231341Z BlobNotFoundThe specified blob does not exist. RequestId:40fb43fc-c01e-0039-1d02-1278cd000000 Time:2019-05-24T07:30:45.8243477Z BlobNotFoundThe specified blob does not exist. RequestId:bcd4e44b-c01e-013d-7002-12cb1a000000 Time:2019-05-24T07:30:45.8232860Z
860010-1125010100
1 1 1